Literature DB >> 15277778

A risk-adjusted approach to comparing the return on investment in health care programs.

Pedram Sendi1, Maiwenn J Al, Heinz Zimmermann.   

Abstract

The league table approach to rank ordering health care programs according to the incremental cost-effectiveness ratio is a common method to guide policy makers in setting priorities for resource allocation. In the presence of uncertainty, however, ranking programs is complicated by the degree of variability associated with each program. Confidence intervals for cost-effectiveness ratios may be overlapping. Moreover, confidence intervals may include negative ratios and the interpretation of negative cost-effectiveness ratios is ambiguous. We suggest to rank mutually exclusive health care programs according to their rate of return which is defined as the net monetary benefit over the costs of the program. However, how does a program with a higher expected return but higher uncertainty compare to a program with a lower expected return but lower risk? In the present paper we propose a risk-adjusted measure to compare the return on investment in health care programs. Financing a health care program is treated as an investment in a risky asset. The risky asset is combined with a risk-free asset in order to construct a combined portfolio. The weights attributed to the risk-free and risky assets are chosen in such a manner that all programs under consideration exhibit the same degree of uncertainty. We can then compare the performance of the individual programs by constructing a risk-adjusted league table of expected returns.

Mesh:

Year:  2004        PMID: 15277778     DOI: 10.1023/B:IHFE.0000036046.80562.06

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN: 1389-6563


  15 in total

1.  Opportunity costs and uncertainty in the economic evaluation of health care interventions.

Authors:  P Sendi; A Gafni; S Birch
Journal:  Health Econ       Date:  2002-01       Impact factor: 3.046

2.  Cost-effectiveness analysis with risk aversion.

Authors:  J G Zivin
Journal:  Health Econ       Date:  2001-09       Impact factor: 3.046

3.  Stochastic league tables: communicating cost-effectiveness results to decision-makers.

Authors:  R C Hutubessy; R M Baltussen; D B Evans; J J Barendregt; C J Murray
Journal:  Health Econ       Date:  2001-07       Impact factor: 3.046

4.  Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations.

Authors:  Pedram Sendi; Maiwenn J Al; Amiram Gafni; Stephen Birch
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

5.  Changing the problem to fit the solution: Johannesson and Weinstein's (mis) application of economics to real world problems.

Authors:  S Birch; A Gafni
Journal:  J Health Econ       Date:  1993-12       Impact factor: 3.883

Review 6.  Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?

Authors:  S Birch; A Gafni
Journal:  J Health Econ       Date:  1992-10       Impact factor: 3.883

7.  Adapting portfolio theory for the evaluation of multiple investments in health with a multiplicative extension for treatment synergies.

Authors:  J F P Bridges; M Stewart; M T King; K van Gool
Journal:  Eur J Health Econ       Date:  2002

8.  Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane.

Authors:  A Briggs; P Fenn
Journal:  Health Econ       Date:  1998-12       Impact factor: 3.046

9.  Some guidelines on the use of cost effectiveness league tables.

Authors:  J Mason; M Drummond; G Torrance
Journal:  BMJ       Date:  1993-02-27

10.  Cost-effectiveness league tables: more harm than good?

Authors:  M Drummond; G Torrance; J Mason
Journal:  Soc Sci Med       Date:  1993-07       Impact factor: 4.634

View more
  4 in total

Review 1.  Reviewing the benefits and costs of electronic health records and associated patient safety technologies.

Authors:  Nir Menachemi; Robert G Brooks
Journal:  J Med Syst       Date:  2006-06       Impact factor: 4.460

2.  Bridging the gap between health and non-health investments: moving from cost-effectiveness analysis to a return on investment approach across sectors of economy.

Authors:  Pedram Sendi
Journal:  Int J Health Care Finance Econ       Date:  2008-03-20

3.  Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches.

Authors:  Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2022-02-09       Impact factor: 4.558

4.  Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve.

Authors:  Pedram Sendi
Journal:  Pharmacoeconomics       Date:  2020-10-31       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.